Titre :
  • Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982).
Auteur : van Herpen, C M L ; Locati, L D ; Buter, J ; Thomas, José ; Bogaerts, J ; Lacombe, Denis ; de Mulder, Pieter ; Awada, Ahmad ; Licitra, L ; Bernier, J ; Vermorken, Jan Baptist
Informations sur la publication : European journal of cancer, 44, 17, (page 2542-2545)
Statut de publication : Publié, 2008-11
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Adenoid cystic carcinoma
Gemcitabine
Head and neck cancer
Salivary gland tumours
Mots-clés MeSH : Adult
Aged
Antimetabolites, Antineoplastic -- administration & dosage
Antimetabolites, Antineoplastic -- adverse effects
Carcinoma, Adenoid Cystic -- drug therapy
Deoxycytidine -- administration & dosage
Deoxycytidine -- adverse effects
Deoxycytidine -- analogs & derivatives
Female
Head and Neck Neoplasms -- drug therapy
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasm Recurrence, Local -- drug therapy
Patient Compliance
Treatment Outcome
Note : Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0959-8049 
info:doi/10.1016/j.ejca.2008.08.014
info:pii/S0959-8049(08)00663-1
info:pmid/18819792